BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 11704768)

  • 1. [An update on the susceptibility of Stenotrophomonas maltophilia].
    Sevillano D; Valdezate S; Gómez-Lus ML
    Rev Esp Quimioter; 2001 Jun; 14(2):138-54. PubMed ID: 11704768
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibiotic susceptibility of Stenotrophomonas maltophilia in the presence of lactoferrin.
    Qamruddin AO; Alkawash MA; Soothill JS
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4425-6. PubMed ID: 16189141
    [No Abstract]   [Full Text] [Related]  

  • 3. Genotype and antibiotic susceptibility patterns of Pseudomonas aeruginosa and Stenotrophomonas maltophilia isolated from cystic fibrosis patients.
    Nazik H; Ongen B; Erturan Z; Salcioğlu M
    Jpn J Infect Dis; 2007 May; 60(2-3):82-6. PubMed ID: 17515637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular epidemiology and antimicrobial susceptibility of Stenotrophomonas maltophilia in a Bulgarian university hospital over a 5-year period (2007-2012).
    Bojkova M; Markovska R; Stoeva T; Strateva T; Ivanova D; Popova V; Mitov I
    Infect Dis (Lond); 2015; 47(12):932-4. PubMed ID: 26198085
    [No Abstract]   [Full Text] [Related]  

  • 5. Expression of multidrug efflux pump SmeDEF by clinical isolates of Stenotrophomonas maltophilia.
    Alonso A; Martinez JL
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1879-81. PubMed ID: 11353642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survey of gut colonisation with Stenotrophomonas maltophilia among neonates.
    Basu S; Das P; Roy S; De S; Singh A
    J Hosp Infect; 2009 Jun; 72(2):183-5. PubMed ID: 19380180
    [No Abstract]   [Full Text] [Related]  

  • 7. An epidemiological analysis of Stenotrophomonas maltophilia strains in a university hospital.
    Caylan R; Kaklikkaya N; Aydin K; Aydin F; Yilmaz G; Ozgumus B; Koksal I
    Jpn J Infect Dis; 2004 Apr; 57(2):37-40. PubMed ID: 15118205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stenotrophomonas maltophilia: antimicrobial resistance and molecular typing of an emerging pathogen in a Turkish university hospital.
    Gülmez D; Hasçelik G
    Clin Microbiol Infect; 2005 Nov; 11(11):880-6. PubMed ID: 16216102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial Resistance in
    Wang Y; He T; Shen Z; Wu C
    Microbiol Spectr; 2018 Jan; 6(1):. PubMed ID: 29350131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stenotrophomonas maltophilia as a nosocomial pathogen.
    Köseoğlu O; Sener B; Gülmez D; Altun B; Gür D
    New Microbiol; 2004 Jul; 27(3):273-9. PubMed ID: 15460530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stenotrophomonas maltophilia intestinal colonization in hospitalized oncology patients with diarrhea.
    Apisarnthanarak A; Fraser VJ; Dunne WM; Little JR; Hoppe-Bauer J; Mayfield JL; Polish LB
    Clin Infect Dis; 2003 Oct; 37(8):1131-5. PubMed ID: 14523780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudooutbreak of Stenotrophomonas maltophilia bacteremia in a general ward.
    Park YS; Kim SY; Park SY; Kang JH; Lee HS; Seo YH; Cho YK
    Am J Infect Control; 2008 Feb; 36(1):29-32. PubMed ID: 18241733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer.
    Safdar A; Rolston KV
    Clin Infect Dis; 2007 Dec; 45(12):1602-9. PubMed ID: 18190323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major facilitator superfamily MfsA contributes to multidrug resistance in emerging nosocomial pathogen Stenotrophomonas maltophilia.
    Dulyayangkul P; Charoenlap N; Srijaruskul K; Mongkolsuk S; Vattanaviboon P
    J Antimicrob Chemother; 2016 Oct; 71(10):2990-1. PubMed ID: 27334664
    [No Abstract]   [Full Text] [Related]  

  • 15. Stenotrophomonas maltophilia: the significance and role as a nosocomial pathogen.
    Senol E
    J Hosp Infect; 2004 May; 57(1):1-7. PubMed ID: 15142709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular epidemiology of Stenotrophomonas maltophilia strains isolated from paediatric patients].
    Köseoğlu O; Sener B; Gür D
    Mikrobiyol Bul; 2004; 38(1-2):9-19. PubMed ID: 15293897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial susceptibility profile of molecular typed cystic fibrosis Stenotrophomonas maltophilia isolates and differences with noncystic fibrosis isolates.
    Cantón R; Valdezate S; Vindel A; Sánchez Del Saz B; Maíz L; Baquero F
    Pediatr Pulmonol; 2003 Feb; 35(2):99-107. PubMed ID: 12526070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A meningitis case due to Stenotrophomonas maltophilia and review of the literature.
    Yemisen M; Mete B; Tunali Y; Yentur E; Ozturk R
    Int J Infect Dis; 2008 Nov; 12(6):e125-7. PubMed ID: 18579427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stenotrophomonas maltophilia responsible for respiratory infections in neonatal intensive care unit: antibiotic susceptibility and molecular typing.
    Abbassi MS; Touati A; Achour W; Cherif A; Jabnoun S; Khrouf N; Ben Hassen A
    Pathol Biol (Paris); 2009 Jul; 57(5):363-7. PubMed ID: 18178029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and Characterization of Stenotrophomonas maltophilia Isolates from a Brazilian Hospital.
    Gallo SW; Figueiredo TP; Bessa MC; Pagnussatti VE; Ferreira CA; Oliveira SD
    Microb Drug Resist; 2016 Dec; 22(8):688-695. PubMed ID: 27007167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.